Laboratory quality control issues related to screening newborns for cystic fibrosis using immunoreactive trypsin.

Hassemer, D J; Laessig, R H; Hoffman, G L; Farrell, P M

Hassemer, D J; Laessig, R H; Hoffman, G L; Farrell, P M.

Affiliation

Hassemer DJ; State Laboratory of Hygiene, Madison, WI 53706.

Pediatr Pulmonol Suppl ; 7: 76-83, 1991.

Article in En | MEDLINE | ID: mdl-1782137

Subject(s)

Cystic Fibrosis/prevention & control; Neonatal Screening/standards; Quality Control; Trypsin/blood; Cystic Fibrosis/diagnosis; Cystic Fibrosis/epidemiology; Electronic Data Processing; Evaluation Studies as Topic; Humans; Infant, Newborn; Laboratories; Predictive Value of Tests; Wisconsin/epidemiology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Quality Control / Trypsin / Neonatal Screening / Cystic Fibrosis Type of study: Clinical_trials / Diagnostic_studies / Evaluation_studies / Prognostic_studies / Screening_studies Limits: Humans / Newborn Country/Region as subject: America do norte Language: En Journal: Pediatr Pulmonol Suppl Journal subject: PEDIATRIA Year: 1991 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links